B D Vallance

514 total citations
11 papers, 444 citations indexed

About

B D Vallance is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B D Vallance has authored 11 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B D Vallance's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Vitamin C and Antioxidants Research (2 papers). B D Vallance is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipoproteins and Cardiovascular Health (5 papers) and Vitamin C and Antioxidants Research (2 papers). B D Vallance collaborates with scholars based in United Kingdom and United States. B D Vallance's co-authors include Muriel Caslake, J. Shepherd, Bruce A. Griffin, A R Lorimer, C.J. Packard, A Gaw, C.J. Packard, G.M. Lindsay, Robert Hume and Elspeth Weyers and has published in prestigious journals such as Heart, Drugs and Journal of Clinical Pathology.

In The Last Decade

B D Vallance

11 papers receiving 416 citations

Peers

B D Vallance
P.M.J. Stuyt Netherlands
G. J. Miller United Kingdom
T. LINDÉN Sweden
D W Garber United States
H. Zeller Germany
James T. Ogilvie United States
P.M.J. Stuyt Netherlands
B D Vallance
Citations per year, relative to B D Vallance B D Vallance (= 1×) peers P.M.J. Stuyt

Countries citing papers authored by B D Vallance

Since Specialization
Citations

This map shows the geographic impact of B D Vallance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B D Vallance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B D Vallance more than expected).

Fields of papers citing papers by B D Vallance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B D Vallance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B D Vallance. The network helps show where B D Vallance may publish in the future.

Co-authorship network of co-authors of B D Vallance

This figure shows the co-authorship network connecting the top 25 collaborators of B D Vallance. A scholar is included among the top collaborators of B D Vallance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B D Vallance. B D Vallance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Balachandran, Kanarath, et al.. (2002). Rescue percutaneous coronary intervention for failed thrombolysis: results from a district general hospital. Postgraduate Medical Journal. 78(920). 330–334. 10 indexed citations
2.
Duncan, Andrew, et al.. (1995). Iatrogenic profound hypoalphalipoproteinaemia: an unrecognised cause of very low HDL cholesterol. Postgraduate Medical Journal. 71(838). 498–500. 2 indexed citations
3.
Gaw, A, Chris J. Packard, Muriel Caslake, et al.. (1994). Effects of ciprofibrate on LDL metabolism in man. Atherosclerosis. 108(2). 137–148. 45 indexed citations
4.
Gaw, A., C.J. Packard, G.M. Lindsay, et al.. (1993). Effects of simvastatin on apoB metabolism and LDL subfraction distribution.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(2). 170–189. 93 indexed citations
5.
Caslake, Muriel, C.J. Packard, A Gaw, et al.. (1993). Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(5). 702–711. 103 indexed citations
6.
Anderton, J. L., et al.. (1988). Atenolol and Sustained Release Nifedipine Alone and in Combination in Hypertension. Drugs. 35(Supplement 4). 22–26. 16 indexed citations
7.
Shepherd, J., Muriel Caslake, A R Lorimer, B D Vallance, & C.J. Packard. (1985). Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 5(2). 162–168. 81 indexed citations
8.
Watson, W S, et al.. (1982). The Effect of Megadose Ascorbic Acid Ingestion on the Absorption and Retention of Vitamin B12 in Man. Scottish Medical Journal. 27(3). 240–243. 5 indexed citations
9.
Hume, Robert, et al.. (1982). Ascorbate status and fibrinogen concentrations after cerebrovascular accident.. Journal of Clinical Pathology. 35(2). 195–199. 13 indexed citations
10.
Shepherd, James, Christopher J. Packard, Jennifer M. Stewart, et al.. (1980). The relationship between the cholesterol content and subfraction distribution of plasma high-density lipoproteins. Clinica Chimica Acta. 101(1). 57–62. 47 indexed citations
11.
Vallance, B D, Robert Hume, & Elspeth Weyers. (1978). Reassessment of changes in leucocyte and serum ascorbic acid after acute myocardial infarction.. Heart. 40(1). 64–68. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026